News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Naoto T Ueno: Findings on Anthracyclines in HER2-Positive Inflammatory Breast Cancer
Naoto Ueno/LinkedIn
Aug 9, 2025, 06:29

Naoto T Ueno: Findings on Anthracyclines in HER2-Positive Inflammatory Breast Cancer

Naoto T Ueno, Director of the University of Hawaii Cancer Center, shared a post on X:

“A study finds no difference in pCR between regimens with or without anthracyclines in HER2-positive inflammatory breast cancer (IBC). But those on anthracyclines had better disease control. More research needed.”

Title: Neoadjuvant HER2-targeted regimens with or without anthracyclines for HER2-positive inflammatory breast cancer: a multicenter retrospective study

Authors: Toshiaki Iwase, Nithya Sridhar, Megumi Kai, Wenli Dong, Yu Shen, Savitri Krishnamurthy, Anthony Lucci, H. T. Carisa Le-Petross, Azadeh Nasrazadani, Sadia Saleem, Rachel M. Layman, Vincente Valero, Debasish Tripathy, Wendy A. Woodward, Yee Chung Cheng, Faina Nakhlis, Jenifer R. Bellon, Filipa Lynce, Naoto T. Ueno

Read the Full Article.

Naoto T Ueno

More posts featuring Naoto T Ueno.

Anthony Lucci Azadeh Nasrazadani cancer Debasish Tripathy Faina Nakhlis Filipa Lynce H T Carisa Le-Petross inflammatory breast cancer Jenifer R. Bellon Megumi Kai Naoto T Ueno Nithya Sridhar OncoDaily Oncology Rachel M. Layman Sadia Saleem Savitri Krishnamurthy Toshiaki Iwase Vincente Valero Wendy A. Woodward Wenli Dong Yee Chung Cheng Yu Shen
Special Coverage
Science
Aug 9, 2025, 11:44
Sylvester Researchers Uncover Molecular Drivers of Cellular Differentiation
Voices
Aug 9, 2025, 11:37
Jasmine Kamboj: How We Bring Ourselves to the Table as Leaders
Voices
Aug 9, 2025, 11:29
Lillian Siu: Registration is Open for the 2025 FDA-AACR-SITC Workshop
Voices
Aug 9, 2025, 11:12
Promising R&D Pipeline Includes 36 Projects in Clinical Development
Insight
Aug 9, 2025, 11:04
A Collaborative Pediatric Cancer Research Awards Program by Rally Foundation
Voices
Aug 9, 2025, 10:59
Mikkael Sekeres: Steps to Avoid Chemicals and How Concerned You Should Be
Voices
Aug 9, 2025, 10:52
Yelena Janjigian: My Mom, a Great Supporter of Science and Cancer Research
Voices
Aug 9, 2025, 10:47
What Do IDH, MGMT, and TERT Have to Do with Brain Tumors? - WeTrials
Voices
Aug 9, 2025, 10:45
Julie S. Torode: Excited to Join World Radiotherapy Awareness Day on September 7
Dialogues
Aug 9, 2025, 10:44
Beyond the Cancer Diagnosis: Interview with Muna Al-Khaifi, by Adrian Pogacian
Science
Aug 9, 2025, 10:40
Ibrahim Halil Sahin: Exclusiveness of BRAF Alterations and HER2 Amplification in Colorectal Cancer
Blog
Aug 9, 2025, 10:38
C Is for Criteria - City Cancer Challenge